Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
09.01.2015 - 19.01.2015
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2015
Report date:
2015

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
4-(2-bromoacetyl)-3-[(methoxycarbonyl)oxy]phenyl methyl carbonate
EC Number:
807-596-9
Cas Number:
1428451-07-3
Molecular formula:
C12H11BrO7
IUPAC Name:
4-(2-bromoacetyl)-3-[(methoxycarbonyl)oxy]phenyl methyl carbonate
Test material form:
solid: bulk

In vitro test system

Test system:
human skin model
Vehicle:
water
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Duration of post-treatment incubation (if applicable):
15 min
Number of replicates:
3

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Main experiment
Value:
> 93.2 - < 101.6
Vehicle controls validity:
not examined
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation

Any other information on results incl. tables

1. Pre-Experiments

The mixture of 10 mg test item per 2 mL MTT medium showed no reduction of MTT compared to the solvent. The mixture did not turn blue/purple. The mixture of 10 mg of the test item per 90 μL aqua dest. showed no colouring detectable by unaided eye-assessment.

2. Experiment

Table 1: Result of the test with 2’,4’-Bis(methoxycarbonyloxy)-2-brom-acetophenone

Name

Negative Control (NC)

Positive Control (PC)

Test Item

Tissue

1

2

3

1

2

3

1

2

3

absolute OD550

0.937

0.911

0.923

0.960

0.934

0.937

0.116

0.119

0.129

0.125

0.115

0.110

0.911

0.917

0.857

0.889

0.963

0.932

OD550(blank-corrected)

0.893

0.867

0.880

0.916

0.890

0.893

0.072

0.076

0.085

0.081

0.071

0.066

0.867

0.873

0.814

0.845

0.919

0.889

mean OD550of the duplicates (blank-corrected)

0.880

0.898

0.892

0.074

0.083

0.068

0.870

0.829

0.904

total mean OD550of 3 replicate tissues (blank corrected)

0.890*

0.075

0.868

SD OD550

0.009

0.007

0.037

relative tissue viabilities [%]

98.9

100.9

100.2

8.3

9.3

7.7

97.7

93.2

101.6

mean relative tissue viability [%]

100.0

8.4**

97.5

SD tissue viability [%]***

1.0

0.8

4.2

CV [% viability]

1.0

9.9

4.3

* Corrected mean OD550 of the negative control corresponds to 100% absolute tissue viability.

** mean relative tissue viability of the three positive control tissues is40%

*** The standard deviation (SD) obtained from the three concurrently tested tissues is < 18 %.

3. Quality Criteria

Table 2: Qualitiy Criteria

 

Value

Cut off

pass / fail

Mean OD550blank

0.044

< 0.1

pass

Mean Absolute OD550NC

0.934

0.6 ≤ NC ≤ 1.5

pass

Mean Relative Viability [%] PC

8.4

≤ 40 %

pass

SD of Viability [%]

0.8 – 4.2

< 18 %

pass

4. Historical Data

Table 3: Historical Data

 

OD550blank

Absolute OD550NC

Relative Viability [%] PC

SD of Viability [%]

Mean

0.043

0.869

12.50

8.01

SD

0.002

0.122

8.67

8.63

n

44

44

44

176

5. Dicussion and Conclusion

The potential of the test item to induce skin irritation was analysed by using the three-dimensional human skin model EPISKIN-SM TM (SkinEthic) comprising a reconstructed epidermis with a functional stratum corneum. In the present study 2’,4’-Bis(methoxycarbonyloxy)-2-brom-acetophenone was applied topically to the EPISKIN-SM TM tissue for 15 min. followed by a 42 h postincubation period and immediate determination of cytotoxic effects via MTT reduction assay. Irritant potential of the test item was predicted from the relative mean tissue viabilities obtained compared to the corresponding negative control tissues concurrently treated with PBS. The test item showed no irritant effects. The mean relative tissue viability (% negative control) was > 50% (102.3%) after 15 min. treatment and 42 h post incubation. The controls confirmed the validity of the study. The mean OD550 of the six blank values was < 0.1. The mean absolute OD550 of the three negative control tissues was≥ 0.6 and≤ 1.5.The mean relative tissue viability (% negative control) of the positive control was 40 % (8.4 %). The maximum standard deviation of the viability of replicate tissues of all dose groups was < 18 % (0.8 - 4.2 %)

Under the given conditions the test item showed no irritant effects. The test item is therefore classified as “non-irritant” in accordance with UN GHS “No Category”.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
2’,4’-Bis(methoxycarbonyloxy)-2-brom-acetophenone was not irritating in an in vitro skin irritation test (reconstructed human epidermis test method) according to OECD 439 and EU-Method B.46.
Executive summary:

In the present study the skin irritant potential of 2’,4’-Bis(methoxycarbonyloxy)-2-brom-acetophenone was analysed. The EPISKINStandard Model™ (EPISKIN-SMTM), a reconstituted three-dimensional human epidermis model, was used as a replacement for the Draize Skin Irritation Test (OECD TG 404) to distinguish between UN GHS “Category 2” skin irritating test substances and not categorized test substances (“No Category”) which may be considered as non-irritant. Hereby, the test item was applied topically. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT after a 15 min exposure and 42 h post incubation period and compared to those of the concurrent negative controls.

Under the given conditions 2’,4’-Bis(methoxycarbonyloxy)-2-brom-acetophenone showed no irritant effects. The relative mean tissue viability after 15 min of exposure and 42 h post incubation was > 50%. The test item is therefore classified as“non-irritant” in accordance with UN GHS “No Category”.